BioHealth News
Navigating the Future of Autoimmune Medicine: A Conversation with Dr. Theresa Podrebarac, Senior Vice President, Clinical Development at Horizon Therapeutics
How can patients help shape the future of scientific innovation? What's the vital role of the patient's voice in developing life-changing medicines? In this…
Read MoreTEDCO invests in AGED Diagnostics
COLUMBIA, Md. (September 28, 2023) –TEDCO, Maryland’s economic engine for technology companies, announced a recent $200,000 Seed Funds investment into AGED Diagnostics, a biotechnology company. Previously, AGED…
Read MoreDeka Biosciences Closes USD $20 Million Series B2 Financing Led by MPM BioImpact
GERMANTOWN, Md., Sept. 28, 2023 /PRNewswire/ -- Maryland-based biotech company Deka Biosciences ("Deka") today announced that it has successfully closed a USD $20 Million Series B2 financing with a…
Read MoreMaryland Department of Commerce: Maryland, together with D.C and Virginia, now a “Top 3” biopharma cluster
The latest rankings from Genetic Engineering & Biotechnology News (or GEN) included some long-awaited good news for Maryland: the Biohealth Capital Region (BHCR) had moved up…
Read MoreTheradaptive Awarded DOD Clinical Trial Award of up to $7.4 Million
FREDERICK, Md., September 26, 2023: Today, Theradaptive, a leading biopharmaceutical company using protein engineering to create targeted therapeutics, has been awarded a U.S. Department…
Read MoreEmmes Introduces Telehealth Capabilities into Advantage eClinical
The latest upgrade is part of wider goals to create the industry's first unified digital data platform for decentralized and hybrid trials ROCKVILLE, Md., Sept. 27, 2023 /PRNewswire/…
Read MoreMaryland Department of Commerce Webinar Event: Reach Your Raise: Attract Investors with Maryland’s Biotech Tax Credit
If your Maryland-based life sciences company is doing R&D in biotechnology and preparing to raise equity funding, your investors may be eligible to benefit…
Read MoreAnzu Partners Closes Third Venture Fund Focused on Companies Enabling Next-Gen Solutions in Clean Tech, Industrial, and Life Sciences Technologies
Fund III cohort accelerates the energy transition, facilitates discovery of better therapeutics and advances critical industries ATLANTA & BOSTON & SAN DIEGO & TAMPA,…
Read MoreThe BioHealth Capital Region Successfully Hosted Its Annual Forum, Crab Trap, and Investment Conference
The BioHealth Capital Region continued its tradition of fostering innovation, collaboration, and growth in the life sciences sector with its series of events in…
Read MoreWomen Building Bio 2023
Virginia Bio’s Women Building Bio Conference celebrates the contribution of women to the life sciences in the Commonwealth and beyond. The 8th annual conference…
Read MoreImmediate Opening for a Technical Grant Writer and Project Manager with BioHealth Innovation, Inc.
Opening – Technical Writer and Project Manager BioHealth Innovation (BHI) is an innovation intermediary that facilitates commercialization of emerging technologies in the BioHealth Capital…
Read MoreTEDCO Invests in Natáur
COLUMBIA, Md. (September 25, 2023) – TEDCO, Maryland’s economic engine for technology companies, announced a recent $200,000 investment into Natáur. This recent investment came…
Read MoreWashington DC’s VerImmune Announces Over $3M Additional Funding
WASHINGTON, Sept. 20, 2023 /PRNewswire/ -- VerImmune Inc. ("VerImmune"), an early-stage biotechnology company specializing in the development of innovative products based on a novel…
Read MoreUnited Therapeutics Announces Recent Milestones for its Heart and Kidney Xenotransplantation Programs
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced the achievement of two milestones for…
Read MoreLuminoah Wins 8th Annual Crab Trap Competition at BioHealth Capital Region Forum
Luminoah Wins 8th Annual Crab Trap Competition at BioHealth Capital Region Forum Rockville, MD, September 22, 2023 — Luminoah, a MedTech startup located in…
Read More